145 related articles for article (PubMed ID: 28966279)
1. Rapid Analysis of DOXIL Stability and Drug Release from DOXIL by HPLC Using a Glycidyl Methacrylate-Coated Monolithic Column.
Kimoto A; Watanabe A; Yamamoto E; Higashi T; Kato M
Chem Pharm Bull (Tokyo); 2017; 65(10):945-949. PubMed ID: 28966279
[TBL] [Abstract][Full Text] [Related]
2. A Simple and Easy Method of Monitoring Doxorubicin Release from a Liposomal Drug Formulation in the Serum Using Fluorescence Spectroscopy.
Watanabe A; Murayama S; Karasawa K; Yamamoto E; Morikawa S; Takita R; Murata S; Kato M
Chem Pharm Bull (Tokyo); 2019; 67(4):367-371. PubMed ID: 30930441
[TBL] [Abstract][Full Text] [Related]
3. Leakage kinetics of the liposomal chemotherapeutic agent Doxil: The role of dissolution, protonation, and passive transport, and implications for mechanism of action.
Russell LM; Hultz M; Searson PC
J Control Release; 2018 Jan; 269():171-176. PubMed ID: 29122661
[TBL] [Abstract][Full Text] [Related]
4. A physiologically-based nanocarrier biopharmaceutics model to reverse-engineer the in vivo drug release.
Nagpal S; Braner S; Modh H; Tan AXX; Mast MP; Chichakly K; Albrecht V; Wacker MG
Eur J Pharm Biopharm; 2020 Aug; 153():257-272. PubMed ID: 32589926
[TBL] [Abstract][Full Text] [Related]
5. Determination of key parameters for a mechanism-based model to predict Doxorubicin release from actively loaded liposomes.
Csuhai E; Kangarlou S; Xiang TX; Ponta A; Bummer P; Choi D; Anderson BD
J Pharm Sci; 2015 Mar; 104(3):1087-98. PubMed ID: 25561354
[TBL] [Abstract][Full Text] [Related]
6. Enrichment of liposomal nanomedicines using monolithic solid phase extraction discs following preactivation with bivalent metal ion solutions.
Watanabe A; Karasawa K; Murayama S; Sano Y; Takagi M; Yamamoto E; Murata S; Kato M
J Chromatogr A; 2018 Aug; 1564():224-227. PubMed ID: 29907411
[TBL] [Abstract][Full Text] [Related]
7. Pharmaceutical and biomedical differences between micellar doxorubicin (NK911) and liposomal doxorubicin (Doxil).
Tsukioka Y; Matsumura Y; Hamaguchi T; Koike H; Moriyasu F; Kakizoe T
Jpn J Cancer Res; 2002 Oct; 93(10):1145-53. PubMed ID: 12417045
[TBL] [Abstract][Full Text] [Related]
8. Development of a Flow-Through USP-4 Apparatus Drug Release Assay to Evaluate Doxorubicin Liposomes.
Yuan W; Kuai R; Dai Z; Yuan Y; Zheng N; Jiang W; Noble C; Hayes M; Szoka FC; Schwendeman A
AAPS J; 2017 Jan; 19(1):150-160. PubMed ID: 27485642
[TBL] [Abstract][Full Text] [Related]
9. Heating treatments affect the thermal behaviour of doxorubicin loaded in PEGylated liposomes.
Perinelli DR; Cespi M; Bonacucina G; Rendina F; Palmieri GF
Int J Pharm; 2017 Dec; 534(1-2):81-88. PubMed ID: 28993166
[TBL] [Abstract][Full Text] [Related]
10. In vitro experiments showing enhanced release of doxorubicin from Doxil® in the presence of ammonia may explain drug release at tumor site.
Silverman L; Barenholz Y
Nanomedicine; 2015 Oct; 11(7):1841-50. PubMed ID: 26115641
[TBL] [Abstract][Full Text] [Related]
11. Trimethylammonium modification of a polymer-coated monolith column for rapid and simultaneous analysis of nanomedicines.
Kato M; Athumi Y; Yamaguchi M; Date H; Yamamoto E; Murayama S; Karasawa K
J Chromatogr A; 2020 Apr; 1617():460826. PubMed ID: 31902575
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Physicochemical Properties of Generic Doxorubicin HCl Liposome Injection with the Reference Listed Drug.
Maiti K; Bhowmick S; Jain P; Zope M; Doshi K; Rajamannar T
Anticancer Agents Med Chem; 2018; 18(4):597-609. PubMed ID: 29173186
[TBL] [Abstract][Full Text] [Related]
13. Insights into composition/structure/function relationships of Doxil® gained from "high-sensitivity" differential scanning calorimetry.
Wei X; Cohen R; Barenholz Y
Eur J Pharm Biopharm; 2016 Jul; 104():260-70. PubMed ID: 27106607
[TBL] [Abstract][Full Text] [Related]
14. High performance liquid chromatography analysis of 100-nm liposomal nanoparticles using polymer-coated, silica monolithic columns with aqueous mobile phase.
Itoh N; Kimoto A; Yamamoto E; Higashi T; Santa T; Funatsu T; Kato M
J Chromatogr A; 2017 Feb; 1484():34-40. PubMed ID: 28089273
[TBL] [Abstract][Full Text] [Related]
15. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes.
Gabizon A; Catane R; Uziely B; Kaufman B; Safra T; Cohen R; Martin F; Huang A; Barenholz Y
Cancer Res; 1994 Feb; 54(4):987-92. PubMed ID: 8313389
[TBL] [Abstract][Full Text] [Related]
16. Reduced UV-induced degradation of doxorubicin encapsulated in polyethyleneglycol-coated liposomes.
Bandak S; Ramu A; Barenholz Y; Gabizon A
Pharm Res; 1999 Jun; 16(6):841-6. PubMed ID: 10397603
[TBL] [Abstract][Full Text] [Related]
17. Effect of Nanoparticle Surface on the HPLC Elution Profile of Liposomal Nanoparticles.
Itoh N; Yamamoto E; Santa T; Funatsu T; Kato M
Pharm Res; 2016 Jun; 33(6):1440-6. PubMed ID: 26928667
[TBL] [Abstract][Full Text] [Related]
18. Practical aspects in size and morphology characterization of drug-loaded nano-liposomes.
Peretz Damari S; Shamrakov D; Varenik M; Koren E; Nativ-Roth E; Barenholz Y; Regev O
Int J Pharm; 2018 Aug; 547(1-2):648-655. PubMed ID: 29913218
[TBL] [Abstract][Full Text] [Related]
19. A simple and rapid measurement method of encapsulation efficiency of doxorubicin loaded liposomes by direct injection of the liposomal suspension to liquid chromatography.
Yamamoto E; Miyazaki S; Aoyama C; Kato M
Int J Pharm; 2018 Jan; 536(1):21-28. PubMed ID: 29175642
[TBL] [Abstract][Full Text] [Related]
20. Liposomal Doxorubicin Delivery Systems: Effects of Formulation and Processing Parameters on Drug Loading and Release Behavior.
Mohammadi ZA; Aghamiri SF; Zarrabi A; Talaie MR
Curr Drug Deliv; 2016; 13(7):1065-1070. PubMed ID: 26708673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
